Emodin in atherosclerosis prevention: Pharmacological actions and therapeutic potential

Eur J Pharmacol. 2021 Jan 5:890:173617. doi: 10.1016/j.ejphar.2020.173617. Epub 2020 Oct 1.

Abstract

Atherosclerotic plaque formation, destabilization and eventual rupture leads to the acute cardiovascular events including myocardial infarction and stroke. Emodin (PubChem CID#3220), (1,3,8-trihydroxy-6-methylanthracene-9,10-dione) is a pharmacologically bioactive constituent isolated from the traditional Chinese medicinal herb Radix rhizoma Rhei. This molecule has anti-oxidant, anti-inflammatory, anti-proliferative, anti-apoptotic and lipid-modulating effects. Experimental studies have demonstrated that emodin attenuates and stabilizes atherosclerotic plaques. In this mini-review, we provide a summary of the pharmacological actions of emodin in regulating vascular function and atherosclerosis, highlighting the therapeutic potential of this phytochemical in patients with cardiovascular disease.

Keywords: Atherosclerosis; Cardiovascular disease; Emodin; Therapeutic target.

Publication types

  • Review

MeSH terms

  • Animals
  • Atherosclerosis / drug therapy
  • Atherosclerosis / prevention & control*
  • Blood Platelets / drug effects
  • Drugs, Chinese Herbal / pharmacology*
  • Drugs, Chinese Herbal / therapeutic use
  • Emodin / pharmacology*
  • Emodin / therapeutic use
  • Endothelium / drug effects
  • Humans
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Macrophages / drug effects
  • Muscle, Smooth, Vascular / drug effects

Substances

  • Drugs, Chinese Herbal
  • Emodin